4//SEC Filing
Morrison Scott W 4
Accession 0001662426-25-000005
CIK 0001819790other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:06 PM ET
Size
7.9 KB
Accession
0001662426-25-000005
Insider Transaction Report
Form 4
Morrison Scott W
Director
Transactions
- Exercise/Conversion
Common Stock
2025-09-15+1,334→ 4,684 total - Exercise/Conversion
Restricted Stock Units
2025-09-15−1,334→ 0 total→ Common Stock (1,334 underlying)
Holdings
- 6,016(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F2]The Reporting Person is trustee of the Morrison-Minton Family 2004 Trust, and the Reporting Person and his spouse are the sole beneficiaries of the trust.
- [F3]The RSUs vested in three equal annual installments on September 15th of 2023, 2024, and 2025, subject to the Reporting Person's continuous service.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001662426
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 4:06 PM ET
- Size
- 7.9 KB